moexiprilat has been researched along with angiotensin ii in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grohé, C; Kahlert, S; Lóbbert, K; Neyses, L; Stimpel, M; van Eickels, M; Vetter, H | 2 |
| Grohé, C; Löbbert, K; Stimpel, M; van Eickels, M; Vetter, H | 1 |
3 other study(ies) available for moexiprilat and angiotensin ii
| Article | Year |
|---|---|
Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; DNA-Binding Proteins; Early Growth Response Protein 1; Estrogens; Female; Fibroblasts; Heart; Immediate-Early Proteins; Immunoblotting; Isoquinolines; Male; Rats; Rats, Inbred WKY; Retroviridae Proteins, Oncogenic; Tetrahydroisoquinolines; Transcription Factors | 1997 |
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; Culture Media; Endomyocardial Fibrosis; Estradiol; Estrone; Female; Fibroblasts; Gene Expression; Genes, fos; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Isoquinolines; Male; Menopause; Myocardium; Rats; Sp1 Transcription Factor; Tetrahydroisoquinolines | 1998 |
Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Benzimidazoles; Biphenyl Compounds; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cells, Cultured; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Flavonoids; Heart; Immunoblotting; Isoquinolines; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; STAT3 Transcription Factor; Tetrahydroisoquinolines; Tetrazoles; Time Factors; Trans-Activators | 1999 |